United States · FDA National Drug Code directory
Butalbital, Aspirin, and Caffeine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 79739-7192_1383f9e3-02c6-4363-920c-8e24e51f22e0
- Product NDC
- 79739-7192
- Form
- CAPSULE
- Composition / generic term
- Butalbital, Aspirin, and Caffeine
- Labeler
- LGM PHARMA SOLUTIONS, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211018
- Source listing expiry
- 20261231
Source-listed ingredients
- BUTALBITAL — 50 mg/1
- ASPIRIN — 500 mg/1
- CAFFEINE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (79739-7192-1) · 79739-7192-1
- 500 CAPSULE in 1 BOTTLE (79739-7192-5) · 79739-7192-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →